JPH08504189A - 低／非たんでき性オピオイド鎮痛剤の確認及び使用方法 - Google Patents
低／非たんでき性オピオイド鎮痛剤の確認及び使用方法Info
- Publication number
- JPH08504189A JPH08504189A JP6508375A JP50837594A JPH08504189A JP H08504189 A JPH08504189 A JP H08504189A JP 6508375 A JP6508375 A JP 6508375A JP 50837594 A JP50837594 A JP 50837594A JP H08504189 A JPH08504189 A JP H08504189A
- Authority
- JP
- Japan
- Prior art keywords
- opioid
- analgesic
- dihydroetrophin
- days
- etrophin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94769092A | 1992-09-21 | 1992-09-21 | |
| US947,690 | 1992-09-21 | ||
| US977,322 | 1992-11-17 | ||
| US07/977,322 US5410313A (en) | 1992-11-17 | 1992-11-17 | Functional radar warning receiver back-up generator |
| US8850393A | 1993-07-07 | 1993-07-07 | |
| US088,503 | 1993-07-07 | ||
| PCT/US1993/008869 WO1994006426A1 (en) | 1992-09-21 | 1993-09-17 | Methods for identifying and using low/non-addictive opioid analgesics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH08504189A true JPH08504189A (ja) | 1996-05-07 |
Family
ID=27375994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6508375A Pending JPH08504189A (ja) | 1992-09-21 | 1993-09-17 | 低／非たんでき性オピオイド鎮痛剤の確認及び使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0668764A1 (de) |
| JP (1) | JPH08504189A (de) |
| CA (1) | CA2145207A1 (de) |
| WO (1) | WO1994006426A1 (de) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910132B2 (en) | 1998-09-24 | 2011-03-22 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
| JP2013538849A (ja) * | 2010-09-30 | 2013-10-17 | アストラゼネカ・アクチエボラーグ | 結晶性ナロキソール−ｐｅｇ接合体 |
| US9206190B2 (en) | 2008-12-08 | 2015-12-08 | Euro-Celtique S.A. | Dihydroetorphines and their preparation |
| US10898479B2 (en) | 2013-05-30 | 2021-01-26 | Euro-Celtique S.A. | Dihydroetorphine for the provision of pain relief and anaesthesia |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5512578A (en) * | 1992-09-21 | 1996-04-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists |
| USRE36547E (en) * | 1992-09-21 | 2000-02-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| US5472943A (en) * | 1992-09-21 | 1995-12-05 | Albert Einstein College Of Medicine Of Yeshiva University, | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists |
| US6096756A (en) | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| US5580876A (en) * | 1992-09-21 | 1996-12-03 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| US7220737B1 (en) | 1997-09-04 | 2007-05-22 | Novoneuron, Inc | Noribogaine in the treatment of pain and drug addiction |
| CA2302754C (en) | 1997-09-04 | 2011-11-08 | Novoneuron, Inc. | Noribogaine in the treatment of pain and drug addiction |
| PL341309A1 (en) | 1997-12-22 | 2001-04-09 | Euro Celtique | Method of preventing overdosage of opioidic preparations |
| NZ505193A (en) | 1997-12-22 | 2003-03-28 | Euro Celtique S | Opioid agonist/antagonist combinations |
| US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| DK2517710T3 (en) | 2000-02-08 | 2015-05-26 | Euro Celtique Sa | Oral opioid agonist formulations secured against forgery |
| US6716449B2 (en) | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
| ES2361148T3 (es) | 2001-05-11 | 2011-06-14 | Endo Pharmaceuticals Inc. | Forma de dosificación de opioides de liberación controlada resistente al abuso. |
| WO2003013525A1 (en) | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Opioid agonist formulations with releasable and sequestered antagonist |
| PT1492505E (pt) | 2002-04-05 | 2015-10-06 | Euro Celtique Sa | Preparação farmacêutica contendo oxicodona e naloxona |
| EP2422772A3 (de) | 2002-09-20 | 2012-04-18 | Alpharma, Inc. | Sequestriermitteluntereinheit und zugehörige Zusammensetzungen und Verfahren |
| TWI347201B (en) | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
| EP1702558A1 (de) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Verfahren und Vorrichtung zur Darmtätigkeitserfassung |
| NZ573757A (en) | 2006-06-19 | 2011-11-25 | Alpharma Inc | Coated multilayer oral dosage forms of naltrexone hydrochloride |
| US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
| WO2010036401A1 (en) | 2008-05-01 | 2010-04-01 | The Regents Of The University Of California | Methods and compositions using selective delta opioid receptor-1 agonists, delta opioid receptor-2 antagonists, and/or mu opioid receptor antagonists for treatment of substance-related disorders |
| AU2010223323B2 (en) | 2009-03-10 | 2013-07-04 | Euro-Celtique S.A. | Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
| US8362007B1 (en) | 2010-05-11 | 2013-01-29 | Demerx, Inc. | Substituted noribogaine |
| US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US8765737B1 (en) | 2010-05-11 | 2014-07-01 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| US8637648B1 (en) | 2010-06-22 | 2014-01-28 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8741891B1 (en) | 2010-06-22 | 2014-06-03 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| WO2012012764A1 (en) | 2010-07-23 | 2012-01-26 | Demerx, Inc. | Noribogaine compositions |
| EP2481740B1 (de) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin |
| US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
| EP2788003A4 (de) | 2011-12-09 | 2015-05-27 | Demerx Inc | Phosphatester von noribogain |
| CA2858820C (en) | 2012-01-25 | 2021-08-17 | Demerx, Inc. | Synthetic voacangine |
| US9150584B2 (en) | 2012-01-25 | 2015-10-06 | Demerx, Inc. | Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
| JP2016508979A (ja) | 2012-12-20 | 2016-03-24 | デメレックス， インコーポレイテッド | 置換ノルイボガイン |
| US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
| JP6181770B2 (ja) | 2012-12-31 | 2017-08-16 | ローズ テクノロジーズ | ７β−置換６α，１４α−エテノモルフィナンおよび７β−置換６α，１４α−エタノモルフィナンを調製するための方法 |
| EP3024461B1 (de) | 2013-07-23 | 2020-05-13 | Euro-Celtique S.A. | Kombination aus oxycodon und naloxon für die verwendung bei der behandlung von schmerzen bei patienten mit schmerzen und einer krankheit, die zur intestinaldysbiose und/oder erhöhung der gefahr bakterieller translokation führt |
| CA2989550C (en) | 2014-06-18 | 2023-08-08 | Demerx, Inc. | Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3763167A (en) * | 1970-06-24 | 1973-10-02 | Us Army | Process of purifying oripavines |
| GB8608818D0 (en) * | 1986-04-11 | 1986-05-14 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| US5192507A (en) * | 1987-06-05 | 1993-03-09 | Arthur D. Little, Inc. | Receptor-based biosensors |
| US4891377A (en) * | 1988-12-02 | 1990-01-02 | Board Of Regents Acting For And On Behalf Of University Of Michigan | Transdermal delivery of the narcotic analgesics etorphine and analogs |
| US4906655A (en) * | 1989-01-24 | 1990-03-06 | Warner-Lambert Company | Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents |
-
1993
- 1993-09-17 EP EP93921686A patent/EP0668764A1/de not_active Withdrawn
- 1993-09-17 WO PCT/US1993/008869 patent/WO1994006426A1/en not_active Ceased
- 1993-09-17 CA CA002145207A patent/CA2145207A1/en not_active Abandoned
- 1993-09-17 JP JP6508375A patent/JPH08504189A/ja active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910132B2 (en) | 1998-09-24 | 2011-03-22 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
| US8454996B2 (en) | 1998-09-24 | 2013-06-04 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
| US8512747B2 (en) | 1998-09-24 | 2013-08-20 | Orexo Ab | Pharmaceutical composition for the treatment of acute disorders |
| US9206190B2 (en) | 2008-12-08 | 2015-12-08 | Euro-Celtique S.A. | Dihydroetorphines and their preparation |
| US9481681B2 (en) | 2008-12-08 | 2016-11-01 | Euro-Celtique S.A. | Dihydroetorphines and their preparation |
| US10745406B2 (en) | 2008-12-08 | 2020-08-18 | Euro-Celtique S.A. | Dihydroetorphines and their preparation |
| JP2013538849A (ja) * | 2010-09-30 | 2013-10-17 | アストラゼネカ・アクチエボラーグ | 結晶性ナロキソール−ｐｅｇ接合体 |
| US10898479B2 (en) | 2013-05-30 | 2021-01-26 | Euro-Celtique S.A. | Dihydroetorphine for the provision of pain relief and anaesthesia |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994006426A1 (en) | 1994-03-31 |
| CA2145207A1 (en) | 1994-03-22 |
| EP0668764A1 (de) | 1995-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08504189A (ja) | 低／非たんでき性オピオイド鎮痛剤の確認及び使用方法 | |
| US5624932A (en) | Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction | |
| EP1617832B1 (de) | Zusammensetzungen zur beeinflussung des gewichtsverlusts | |
| EP1327447B1 (de) | Noribogain zur Behandlung von Schmerzen und Drogenabhängigkeit | |
| Gold | Opiate addiction and the locus coeruleus: the clinical utility of clonidine, naltrexone, methadone, and buprenorphine | |
| Baldo et al. | Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two | |
| TW200418475A (en) | Treatment of pain with combinations of nalbuphine and other kappa-opioid receptor agonists and opioid receptor antagonists | |
| JP2002532392A (ja) | エキソ−ｓ−メカミラミン製剤および治療におけるその使用 | |
| Gold et al. | Efficacy of clonidine in opiate withdrawal: a study of thirty patients | |
| Kamerling et al. | Narcotic analgesics, their detection and pain measurement in the horse: a review | |
| US20200331962A1 (en) | Novel therapeutic uses of mu-opiate receptor peptides | |
| JPWO2001014383A1 (ja) | 神経因性疼痛治療剤および神経因性疼痛のモデル動物 | |
| Pol et al. | Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice. | |
| AU1915192A (en) | Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins | |
| JP2001506978A (ja) | 置換１―［２［ビス（アリール）メトキシ］エチル］―ピペラジンおよび―ホモピペラジンのヒドロキシル化類似物の持続性放出誘導体およびそのドパミン再アップテイクの非競合的拮抗物質としての使用 | |
| Jaw et al. | Involvement of κ-opioid receptors in opioid dependence/withdrawal: studies using butorphanol | |
| Mačiulaitis et al. | Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review | |
| Kutz et al. | Rapid heroin detoxification using a single high dose of buprenorphine | |
| Murphree | Clinical pharmacology of potent analgesics | |
| Hibbs et al. | Agents acting at the neuromuscular junction and autonomic ganglia | |
| EP0862462B1 (de) | Kombination aus einem beta rezeptorblocker und einem opioid | |
| EP1879619A2 (de) | Analgetische kombination von natriumkanalblockern mit opioid-antagonisten | |
| WO2016099393A1 (en) | Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists | |
| Huestis | Controlled drug administration studies of high-dose buprenorphine in humans | |
| Lindsey | Effects of monoamine transporter blockers on cocaine self-administration: Relation to dopamine transporter occupancy measured by PET in rhesus monkeys. An investigation of substitute agonist therapeutic strategies for cocaine addiction |